{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:07:29Z","timestamp":1790942849209,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.encep.2010.08.009","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T11:24:53Z","timestamp":1286969093000},"page":"S83-S89","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Prise en charge m\u00e9dicamenteuse de l\u2019anxi\u00e9t\u00e9 chez le patient souffrant de schizophr\u00e9nie"],"prefix":"10.1016","volume":"37","author":[{"given":"F.-J.","family":"Bayl\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"De Chazeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lesturgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Caci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-P.","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.encep.2010.08.009_bib0005","first-page":"211B","article-title":"Angoisse psychotique et angoisse n\u00e9vrotique. Diff\u00e9rence qualitative ou diff\u00e9rence quantitative\u00a0?","volume":"9","author":"Allilaire","year":"1983","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.encep.2010.08.009_bib0010","unstructured":"APA. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, 2nd edition. www.apa.org; 2004."},{"key":"10.1016\/j.encep.2010.08.009_bib0015","first-page":"652","article-title":"Un diagnostic m\u00e9connu\u00a0: la schizophr\u00e9nie chez l\u2019enfant","volume":"161","author":"Bailly","year":"2003","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.encep.2010.08.009_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1383\/psyt.3.10.37.52407","article-title":"Pharmacological strategies for relapse prevention in schizophrenia","volume":"3","author":"Barnes","year":"2004","journal-title":"Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0924-9338(01)00590-9","article-title":"Clinical features of panic attacks in schizophrenia","volume":"16","author":"Bayl\u00e9","year":"2001","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0030","first-page":"741","article-title":"Anxi\u00e9t\u00e9 et schizophr\u00e9nie\u00a0: situation actuelle","volume":"158","author":"Bayl\u00e9","year":"2000","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.encep.2010.08.009_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004714-199506000-00009","article-title":"Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine","volume":"15","author":"Berman","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2010.08.009_bib0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/oxfordjournals.schbul.a033472","article-title":"At issue: hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes","volume":"26","author":"Bermanzohn","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.encep.2010.08.009_bib0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0920-9964(08)70677-7","article-title":"Validation of a new anxiety scale in schizophrenia (EAS scale)","volume":"102","author":"Blanc","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2010.08.009_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/oxfordjournals.schbul.a033336","article-title":"Anhedonia, positive and negative affect and social functioning in schizophrenia","volume":"24","author":"Blanchard","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.encep.2010.08.009_bib0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0447.1987.tb02806.x","article-title":"Schizophrenia: lifetime comorbidity in a community sample","volume":"75","author":"Bland","year":"1987","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.encep.2010.08.009_bib0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00004714-199602000-00007","article-title":"Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients","volume":"16","author":"Blin","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2010.08.009_bib0065","first-page":"543","article-title":"Psychotic Anxiety Scale (PAS)\u00a0: \u00e9valuation de la fid\u00e9lit\u00e9 intercotateurs et analyse factorielle des correspondances","volume":"15","author":"Blin","year":"1989","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.encep.2010.08.009_bib0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1527-3458.2004.tb00023.x","article-title":"Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome","volume":"10","author":"Bourin","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.encep.2010.08.009_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpsychires.2004.09.003","article-title":"Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life","volume":"39","author":"Braga","year":"2005","journal-title":"J Psychiatric Res"},{"key":"10.1016\/j.encep.2010.08.009_bib0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.comppsych.2004.07.009","article-title":"Anxiety disorders in schizophrenia","volume":"45","author":"Braga","year":"2004","journal-title":"Comp Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0085","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1185\/030079904125004510","article-title":"Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials","volume":"20","author":"Buckley","year":"2004","journal-title":"Curr Med Res Opinion"},{"key":"10.1016\/j.encep.2010.08.009_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1440-1819.2001.00879.x","article-title":"Correlation of panic attacks and hostility in chronic schizophrenia","volume":"55","author":"Chen","year":"2001","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2010.08.009_bib0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/00048679809062708","article-title":"The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder","volume":"32","author":"Cosoff","year":"1998","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0010-440X(91)90025-8","article-title":"\u201cPanic-like\u201d symptomatology in schizophrenic and schizoaffective patients with post-psychotic depression: observations and implications","volume":"32","author":"Cutler","year":"1991","journal-title":"Comp Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3928\/02793695-20071101-06","article-title":"Mindfulness: an intervention for anxiety in schizophrenia","volume":"45","author":"Davis","year":"2007","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.encep.2010.08.009_bib0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-9964(97)88822-6","article-title":"Olanzapine versus fluphenazine \u2013 6\u00a0weeks treatment of anxiety symptoms during acute schizophrenia","volume":"29","author":"Dossenbach","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2010.08.009_bib0115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4088\/JCP.v60n1105","article-title":"Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder","volume":"60","author":"Emsley","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0013-7006(06)76280-7","article-title":"Benzodiaz\u00e9pines et schizophr\u00e9nie, revue de la litt\u00e9rature","volume":"32","author":"Gaillard","year":"2006","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.encep.2010.08.009_bib0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0010-440X(91)90075-N","article-title":"Examination of comorbid anxiety in psychiatric inpatients","volume":"32","author":"Garvey","year":"1991","journal-title":"Comp Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0130","first-page":"1","article-title":"Prescription d\u2019antipsychotiques en milieu hospitalier sp\u00e9cialis\u00e9","volume":"82","author":"Gury","year":"2006","journal-title":"Inf Psychiatr"},{"key":"10.1016\/j.encep.2010.08.009_bib0135","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00005053-200110000-00003","article-title":"Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor","volume":"189","author":"Huppert","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.encep.2010.08.009_bib0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1017\/S1092852900019714","article-title":"Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms","volume":"10","author":"Huppert","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.encep.2010.08.009_bib0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","article-title":"Quality of life in schizophrenia: contributions of anxiety and depression","volume":"51","author":"Huppert","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2010.08.009_bib0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/da.20017","article-title":"Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia","volume":"20","author":"Kasper","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.encep.2010.08.009_bib0155","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.1996.01830110060007","article-title":"Lifetime prevalence, demographic risk factors, and diagnostic validity of non-affective psychosis as assessed in a US community sample. The National Comorbidity Survey","volume":"53","author":"Kendler","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2005.07.004","article-title":"Premorbid indicators and risk for schizophrenia: a selective review and update","volume":"79","author":"Keshavan","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2010.08.009_bib0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0447.1998.tb10101.x","article-title":"Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis","volume":"97","author":"Lan\u00e7on","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.encep.2010.08.009_bib0170","series-title":"Encyclop\u00e9die Orphanet","article-title":"La schizophr\u00e9nie","author":"Llorca","year":"2004"},{"key":"10.1016\/j.encep.2010.08.009_bib0175","unstructured":"L\u00f4o H. L\u2019anxi\u00e9t\u00e9 dans les psychoses. In: Lebois-Offset, editor. L\u2019anxi\u00e9t\u00e9. Bar sur Aube; 1977, p. 41\u201357."},{"key":"10.1016\/j.encep.2010.08.009_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.05.014","article-title":"Association of delusions and lack of cognitive flexibility with social anxiety in schizophrenia spectrum disorders","volume":"86","author":"Lysaker","year":"2006","journal-title":"Schizophr Res"},{"issue":"Suppl. 2","key":"10.1016\/j.encep.2010.08.009_bib0185","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1055\/s-2004-832668","article-title":"Mechanisms of relapse prevention in schizophrenia","volume":"37","author":"Muller","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1017\/S003329179800751X","article-title":"Aspects of dysphoria and symptoms of schizophrenia","volume":"28","author":"Norman","year":"1998","journal-title":"Psychol Med"},{"issue":"Suppl.","key":"10.1016\/j.encep.2010.08.009_bib0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1994.tb05867.x","article-title":"The vulnerability\/stress model of schizophrenic relapse: a longitudinal study","volume":"382","author":"Nuechterlein","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.encep.2010.08.009_bib0200","first-page":"595","article-title":"Activit\u00e9 anxiolytique de la cyam\u00e9mazine\u00a0: r\u00f4le des r\u00e9cepteurs s\u00e9rotoninergiques","volume":"83","author":"Nuss","year":"2007","journal-title":"Inf Psychiatr"},{"key":"10.1016\/j.encep.2010.08.009_bib0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.ajp.161.1.53","article-title":"Social anxiety in outpatients with schizophrenia: a relevant cause of disability","volume":"161","author":"Pallanti","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0210","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1176\/ajp.156.12.1998","article-title":"Obsessive-compulsive disorder in patients with first-episode schizophrenia","volume":"156","author":"Poyurovsky","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0215","first-page":"967","article-title":"Cyam\u00e9mazine\u00a0: traitement symptomatique des dimensions anxieuses, impulsives et agressives","volume":"10","author":"Radat","year":"1995","journal-title":"Inf Psychiatr"},{"key":"10.1016\/j.encep.2010.08.009_bib0220","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004714-200008000-00004","article-title":"Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics","volume":"20","author":"Reznik","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2010.08.009_bib0225","first-page":"280","article-title":"Efficacit\u00e9 de l\u2019ac\u00e9tate de zuclopenthixol sur l\u2019anxi\u00e9t\u00e9 psychotique \u00e9valu\u00e9e lors d\u2019une \u00e9tude ouverte","volume":"22","author":"Romain","year":"1996","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.encep.2010.08.009_bib0230","first-page":"643","article-title":"A clinical study of emergent anxiety in neuroleptic-na\u00efve, first-episode schizophrenia patients following treatment with risperidone","volume":"105","author":"Sannomiya","year":"2003","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"10.1016\/j.encep.2010.08.009_bib0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.comppsych.2003.09.002","article-title":"The relationship between insight and symptoms in schizophrenia","volume":"45","author":"Sevy","year":"2004","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.encep.2010.08.009_bib0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/da.10083","article-title":"Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia","volume":"17","author":"Tibbo","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.encep.2010.08.009_bib0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","article-title":"Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale","volume":"30","author":"White","year":"1997","journal-title":"Psychopathology"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700610001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700610001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T20:02:54Z","timestamp":1685822574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700610001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"alternative-id":["S0013700610001934"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2010.08.009","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}